Drug Markets/Iloperidone

Iloperidone

7 NDCs across 1 manufacturer|0 Generic,7 Brand

Iloperidone is used to treat schizophrenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 6, 2009, and the first generic was approved Nov 28, 2016. In 2024, Medicare Part D spent $87 million on Iloperidone across 42,000 claims for 4,229 beneficiaries.

Iloperidone is available as 7 NDCs from 1 manufacturer (0 generic, 7 brand), with NADAC prices from $30.50 to $60.28 per EAa 98% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

7

0G / 7B

Manufacturers

1

competing in market

Price Spread

$30.50 – $60.28

per EA

7d Activity

430 flat

avg +0.1% WoW · of 7 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ILOPERIDONE

Drug Portfolio

7 NDCs total, 7 shown

Frequently Asked Questions

What is Iloperidone used to treat?

Iloperidone is used to treat schizophrenia, per the National Library of Medicine's MED-RT classification.

When did Iloperidone become available as a generic?

FDA approved the first generic Iloperidone (ANDA) on Nov 28, 2016.

How much does Medicare spend on Iloperidone?

In 2024, Medicare Part D spent $87 million on Iloperidone across 42,000 claims for 4,229 beneficiaries.

How many Iloperidone products are on the market?

The Iloperidone drug market contains 7 NDCs from 1 manufacturer — 0 generic and 7 brand products.

What is the price range for Iloperidone?

NADAC reference prices for Iloperidone range from $30.4999 to $60.2757 per EA — a 98% difference between cheapest and most expensive.

Which manufacturers make Iloperidone?

1 manufacturer lists Iloperidone in NADAC. Ranked by number of NDCs, the largest are Vanda Pharmaceuticals Inc. (7).

How has the price of Iloperidone changed recently?

Over the past 7 days, 4 Iloperidone NDCs rose and 3 fell, with a market-wide average change of +0.1%.